In addition to demonstrating dysregulation of several cytokines, we observed that the induction of IL-18 binding protein (IL-18BP), the only known natural inhibitor of IFNγ and Th1 responses in humans [10], [15], was impaired in the FHL patient's blood cells. This evidence concerns the gene IL18BP and hemophagocytic syndrome.